Regenexx Company

Regenexx was the first company that used stem cells to treat orthopedic injuries. Regenexx has published roughly half of all research worldwide on the use of bone marrow concentrate for orthopedic conditions and has created the field of interventional orthopedic protocols, the use of the body’s natural healing abilities to repair orthopedic injuries non-surgically. The approach is rooted in research and is constantly being refined and developed as we continue to lead the way in finding better methods for harnessing your body’s healing agents to repair damaged tissue. The proprietary protocol leads to arguably the world’s most advanced platform for in-office interventional orthopedics. With more than 6 million covered lives across the country, Regenexx uses our advanced regenerative technologies to help self-funded employers save up to 80% of their orthopedic healthcare costs by providing an effective, low-cost alternative to roughly 70% orthopedic surgeries.

Acquisitions Number: 1
Founded Date: 2005
Headquarters: United States
Technology: Autologous Stem Cells
Employee Number: 51-200
Industry: Biotechnology, Health Care
Estimated Revenue: $1M to $10M
Investor Type: For Profit